Q3 2021 VolitionRX Ltd Earnings Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited third-quarter 2021 earnings conference call. (Operator Instructions)
This conference call is being recorded today, November 11, 2021.
I'd now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead.
Thank you, and welcome, everyone, to today's earnings conference call for VolitionRx Limited. This call will cover Volition's financial and operating results for the third quarter of 2021, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session.
Also on our call today are Mr. Cameron Reynolds, President and Chief Executive Officer, Mr. Terig Hughes, our Chief Financial Officer, and Dr. Tom Butera, Chief Executive Officer of Volition Veterinary Diagnostics Development LLC.
Before we begin, I'd like to remind
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |